Skip to main content
Qiagen N.V. logo

Qiagen N.V. — Investor Relations & Filings

Ticker · QIA ISIN · NL0015001WM6 LEI · 54930036WK3GMCN17Z57 F Manufacturing
Filings indexed 626 across all filing types
Latest filing 2025-04-06 Earnings Release
Country NL Netherlands
Listing F QIA

About Qiagen N.V.

https://www.qiagen.com/

Qiagen N.V. is a global provider of "Sample to Insight" solutions, offering technologies that transform biological materials into valuable molecular insights. The company develops and markets sample and assay technologies, automated instrumentation, and bioinformatics software for molecular diagnostics, applied testing, academic research, and pharmaceutical development. Its comprehensive portfolio supports the entire workflow from sample collection and preparation of DNA, RNA, and proteins to analysis and interpretation. Key product areas include sample preparation kits, PCR, digital PCR (dPCR), and next-generation sequencing (NGS) solutions, as well as syndromic testing panels for infectious diseases.

Recent filings

Filing Released Lang Actions
QIAGEN N.V.: QIAGEN announces strong preliminary Q1 2025 results and updates full-year 2025 adjusted earnings per share outlook
Earnings Release Classification · 100% confidence The document is titled 'QIAGEN N.V.: QIAGEN announces strong preliminary Q1 2025 results and updates full-year 2025 adjusted earnings per share outlook'. It explicitly states it is an 'Ad hoc Announcement according to Art. 17 Market Abuse Regulation' and provides preliminary financial figures (Net sales, Adjusted diluted EPS) for Q1 2025 and an updated outlook for FY 2025. This content—the initial release of key financial highlights for a period—is the definition of an Earnings Release (ER). Although it contains an update to the outlook, the primary function is the announcement of preliminary results, not a full, comprehensive report (like 10-K or IR). The document length (4169 chars) is short, suggesting it is an announcement rather than the full financial statement. Q1 2025
2025-04-06 English
Annual financial report 2024
Annual Report Classification · 100% confidence The document is explicitly titled 'Annual Report' and identifies itself as a 'Form 20-F' filing pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2024. It contains comprehensive sections including a Management Report, Corporate Governance, and Consolidated Financial Statements, which aligns perfectly with the definition of a 10-K (or equivalent foreign private issuer annual report). FY 2024
2025-03-31 English
IRANNOTICE
Regulatory Filings
2025-03-28 English
20-F
Annual Report FY 2024
2025-03-28 English
6-K
Regulatory Filings
2025-02-06 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-02-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.